English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
Prizes
The 2024 iCMLf Goldman Prize is awarded to Professor Jeff H Lipton
In acknowledgment of his remarkable contributions to advancing clinical practice in CML, Professor Jeff H Lipton has been awarded the 2024 Goldman Prize. Professor Lipton is a world-renowned thought leader in CML, bone marrow failure syndromes as well as allogeneic stem cell transplant with a profound impact on patient care and advocacy. Until his retirement in December 2023, Jeff Lipton was Clinical Investigator at the Princess Margaret Cancer Centre and Professor of Medicine at the University of Toronto in Canada.
The iCMLf Goldman Prize honors individuals who have demonstrated extraordinary dedication and achievements in the management and treatment of CML.
‘Jeff has devoted his long-standing career to the care of CML patients.
Recognition with the iCMLf Goldman Prize is well deserved’ (Professor Franck Nicolini)
The 2024 iCMLf Prize is awarded to Viji Venkatesh
The 2024 iCMLf Prize has been awarded to Viji Venkatesh, Regional Head, India & South Asia at The Max Foundation. This award recognises her remarkable contributions to advancing cancer care and patient support, particularly in low-resource settings. Throughout her 35 years of experience in leadership roles at The Max Foundation and in many other community roles, Viji has established pioneering initiatives and patient support programs that have made a true difference to so many patients living with cancer in South Asia and beyond.
The iCMLf Prize acknowledges outstanding achievements to low- and middle-income countries to address unequal access to monitoring and treatment of CML.
‘Alongside The Max Foundation’s patient access programs throughout South Asia,
Viji established the Friends of Max patient support group for CML patients, which now has more then 20 local chapters throughout India representing more than 18,000 members. Viji also encouraged patient leaders in the other countries in the region to form similar support groups. She is a global leader in the CML advocacy community and very deserving of the iCMLf Prize’ (Pat-García Gonzalez, CEO of the MAX Foundation)
Recognising those improving CML treatment in Low and Middle Income Countries - the 2023 iCMLf Prize nominees
The iCMLf Prize honours people who have done outstanding work improving CML management under resource-constraint conditions in low and middle-income countries. Each year, we receive many nominations from the CML community for this prize…
And it’s always difficult to make a choice...
This year the iCMLf prize was awarded to Professor Iryna Dyagil and Dr Kostyantyn Kotlyarchuk, two Ukrainian hematologists in recognition of their work for people with CML under the challenging conditions of war and disruption.
In addition, there were also 11 physicians and patient advocates from ten different countries who were nominated for their dedication and life changing work for people with CML.
Today we are taking the opportunity to acknowledge all of the nominees and to thank them for their work to help people with CML in low and middle-income countries – through their research, their clinical practice and through their advocacy.
The 2023 iCMLf Rowley Prize is awarded to Professor Jerry Radich
The iCMLf is delighted to announce that Professor Jerry Radich, Director of the Radich Laboratory and the Molecular Oncology Laboratory at the Fred Hutchinson Cancer Center in Seattle (USA), is the winner of the 2023 Rowley Prize. The iCMLf Rowley Prize is awarded to celebrate people who have made outstanding lifetime contributions to the understanding of the biology of CML.
“I am honored and humbled by receiving the Rowley Prize. To be included in the company of past winners, under the name of the miraculous Janet Rowley, strains my belief and comprehension. I cannot adequately enough thank those who have given me this award, and those in my lab who have actually done the work.” (Professor Jerry Radich)
The 2023 Goldman Prize is awarded to Professor François Guilhot
Professor François Guilhot, an Emeritus Professor of Hematology and the past Director of the Clinical Investigation Center, 1402 INSERM in Poitiers, France, will receive the 2023 iCMLf Goldman Prize. Professor Guilhot receives the award in recognition of his pioneering achievements in important clinical trials in CML and his longstanding leadership in the management of CML. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding lifetime contributions to the management of patients with CML.
"Many great scientists have already received the John Goldman Prize. And I am very honoured to have been selected this year;this award recognizes 35 years of research and care for CML patients.”
(Professor François Guilhot)
The 2023 iCMLf Prize is awarded to two Ukrainian hematologists – Kostyantyn Kotlyarchuk & Iryna Dyagil
The iCMLf Prize in 2023 recognizes the work of Ukrainian hematologists in this time of war and disruption. The iCMLf Directors and Advisors have chosen the two nominated Ukrainian hematologists to jointly accept this prize in 2023:
- Professor Iryna Dyagil
Head of the Department of Radiation Oncohematology, National Scientific Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine,
Kyiv (Ukraine) - Dr Kostyantyn Kotlyarchuk
Head of the Hematology Department SI ‘Institute of Blood Pathology and Transfusion Medicine NAMS’, Lviv (Ukraine)
The iCMLf Prize recognizes outstanding contributions to the improvement of CML under the challenging conditions of low- and middle-income countries with unequal access to monitoring and access.
